-
January 18, 2019 LupinLife’s Corcal Bone & Beauty to launch at Lakme Fashion Week with an initiative to bring #Beautifullystrong real women to the ramp
-
January 8, 2019 Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders
-
January 7, 2019 Lupin receives FDA approval for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg
-
January 7, 2019 Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g
-
December 31, 2018 Lupin receives FDA approval for Clobazam Oral Suspension, 2.5 mg/mL
-
December 24, 2018 Lupin and AbbVie Announce Partnership to Develop and Commercialize Novel Oncology Drug to treat Hematological Cancers
-
December 20, 2018 Lupin’s Pithampur Unit-3 (Indore) receives EIR from US FDA
-
December 20, 2018 Lupin receives tentative US FDA approval for Dimethyl Fumarate Delayed Release Capsules, 120 mg and 240 mgn
-
December 20, 2018 Lupin receives tentative US FDA approval for Tadalafil Tablets USP, 20 mg
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications